Literature DB >> 20931189

CT-guided corticosteroid injection for solitary eosinophilic granuloma of the spine.

Eugenio Rimondi1, Andreas F Mavrogenis, Giuseppe Rossi, Giuseppe Ussia, Andrea Angelini, Pietro Ruggieri.   

Abstract

OBJECTIVE: To evaluate the clinical and imaging outcome of patients with symptomatic eosinophilic granuloma of the spine treated with CT-guided intralesional methylprednisolone injection after biopsy.
MATERIALS AND METHODS: Patients (n =19) with symptomatic solitary eosinophilic granuloma of the spine treated by CT-guided intralesional methylprednisolone injection were retrospectively studied. There were 12 males and seven females with a mean age of 17 years (range, 3-43 years). The mean follow-up was 6 years (median, 4 years; range, 0.5-19 years). Spinal location included the cervical (two patients), thoracic (seven patients), lumbar spine (eight patients), and the sacrum (two patients). Vertebra plana was observed in two patients. All patients had biopsies before treatment.
RESULTS: Complete resolution of pain and healing of the lesion was observed in 17 patients (89.5%); none of these patients had recurrence at the latest examination. Reconstitution of the T1 and L1 vertebra plana was observed in both patients. Two patients initially diagnosed and treated for a solitary eosinophilic granuloma had constant pain after the procedure; in these patients, 6 and 12 months after the procedure, respectively, imaging showed multifocal disease and systemic therapy was administered. Complications related to the procedure were not observed. General anesthesia was administered in two patients because of intolerable pain during the procedure.
CONCLUSIONS: In view of the benign clinical course of eosinophilic granuloma, in patients with symptomatic lesions, CT-guided intralesional corticosteroid injection is a safe and effective outpatient treatment with a low complication rate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20931189     DOI: 10.1007/s00256-010-1045-7

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  42 in total

1.  Langerhans cell histiocytosis of the atlas. A report of three cases.

Authors:  Nobuhiro Tanaka; Yoshinori Fujimoto; Teruaki Okuda; Kazuyoshi Nakanishi; Tadayoshi Sumida; Hideki Manabe; Mitsuo Ochi
Journal:  J Bone Joint Surg Am       Date:  2005-10       Impact factor: 5.284

2.  Vertebra plana-like lesions in children: case report with special emphasis on the differential diagnosis and indications for biopsy.

Authors:  J O'Donnell; L Brown; H Herkowitz
Journal:  J Spinal Disord       Date:  1991-12

3.  Reconstitution of vertebral height in histiocytosis X: a long-term follow-up.

Authors:  M E Nesbit; S Kieffer; G J D'Angio
Journal:  J Bone Joint Surg Am       Date:  1969-10       Impact factor: 5.284

4.  Expression of Epstein-Barr virus in Langerhans' cell histiocytosis.

Authors:  Misuzu Shimakage; Toshiyuki Sasagawa; Michio Kimura; Tatsuya Shimakage; Shiro Seto; Ken Kodama; Haruhiko Sakamoto
Journal:  Hum Pathol       Date:  2004-07       Impact factor: 3.466

5.  Spinal Langerhans' cell histiocytosis in a young adult: case report and therapeutic considerations.

Authors:  P Metellus; R Gana; S Fuentes; A Eusebio; A Adetchessi; H Dufour; F Grisoli
Journal:  Br J Neurosurg       Date:  2007-04       Impact factor: 1.596

Review 6.  Eosinophilic granuloma of the cervical spine.

Authors:  Christoph Bertram; Jürgen Madert; Christoph Eggers
Journal:  Spine (Phila Pa 1976)       Date:  2002-07-01       Impact factor: 3.468

7.  Eosinophil granuloma of the spine.

Authors:  L P Seimon
Journal:  J Pediatr Orthop       Date:  1981       Impact factor: 2.324

8.  Eosinophilic granuloma of the spine with and without vertebra plana: long-term follow-up of six cases.

Authors:  C Villas; R Martínez-Peric; R H Barrios; J L Beguiristain
Journal:  J Spinal Disord       Date:  1993-06

9.  Direct cortisone injection in eosinophilic granuloma of bone: a preliminary report on 11 patients.

Authors:  R Capanna; D S Springfield; P Ruggieri; R Biagini; P Picci; G Bacci; A Giunti; E G Lorenzi; M Campanacci
Journal:  J Pediatr Orthop       Date:  1985 May-Jun       Impact factor: 2.324

10.  Eosinophilic granuloma. A different behaviour in children than in adults.

Authors:  F Plasschaert; C Craig; R Bell; W G Cole; J S Wunder; B A Alman
Journal:  J Bone Joint Surg Br       Date:  2002-08
View more
  6 in total

1.  Neck pain in a 27-year-old man.

Authors:  Addisu Mesfin; Jacob M Buchowski; Mitra Mehrad; Jianwen Xu
Journal:  Clin Orthop Relat Res       Date:  2013-02-15       Impact factor: 4.176

2.  Management of eosinophilic granuloma in pediatric patients: surgical intervention and surgery combined with postoperative radiotherapy and/or chemotherapy.

Authors:  Zhenhai Zhou; Hongqi Zhang; Chaofeng Guo; Honggui Yu; Longjie Wang; Qiang Guo
Journal:  Childs Nerv Syst       Date:  2017-02-28       Impact factor: 1.475

3.  Tumours of the atlas and axis: a 37-year experience with diagnosis and management.

Authors:  A F Mavrogenis; G Guerra; M Romantini; C Romagnoli; R Casadei; P Ruggieri
Journal:  Radiol Med       Date:  2011-11-17       Impact factor: 3.469

4.  Percutaneous CT-guided corticosteroid injection for the treatment of osseous Langerhans cell histocytosis: a three institution retrospective analysis.

Authors:  Connie Y Chang; Julio Brandao Guimares; Gabby Joseph; Marcelo de Toledo Petrilli; Santiago Lozano-Calderon; Miriam A Bredella; Thomas M Link
Journal:  Skeletal Radiol       Date:  2021-10-04       Impact factor: 2.199

Review 5.  Current concepts for the diagnosis and management of eosinophilic granuloma of bone.

Authors:  Andrea Angelini; Andreas F Mavrogenis; Eugenio Rimondi; Giuseppe Rossi; Pietro Ruggieri
Journal:  J Orthop Traumatol       Date:  2016-10-21

6.  Spontaneous remission of eosinophilic granuloma of the maxilla after incisional biopsy: a case report.

Authors:  Alex Vargas; Hernán Ramírez; Pablo Ramírez; Camila Foncea; Bernardo Venegas; Paula Astorga
Journal:  Head Face Med       Date:  2016-06-02       Impact factor: 2.151

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.